| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 02/02/2000 | EP0656117B1 A methodology for selecting superagonists, antagonists and superantagonists of interleukin 6 |
| 02/02/2000 | EP0618812B1 Use of protease nexin-i as an antiinflammatory |
| 02/02/2000 | EP0616535B1 Method of treating viral infections |
| 02/02/2000 | EP0584136B1 Determination of motifs of peptides on mhc molecules |
| 02/02/2000 | EP0539530B1 Purification directed cloning of peptides |
| 02/02/2000 | EP0397834B1 Method for identifying active domains and amino acid residues in polypeptides and hormone variants |
| 02/02/2000 | CN1243545A Plant apple penicillin promoter sequences |
| 02/02/2000 | CN1243544A Novel IFN receptor 1 binding proteins, DNA encoding them, and methods of modulating cellular response to interferons |
| 02/02/2000 | CN1243444A Modified tumor necrosis factor |
| 02/02/2000 | CN1243130A Preparation method for engineering bateria for recombination of human leucocyte medium-18 and its product thereof |
| 02/01/2000 | US6020537 Prion protein standard and method of making same |
| 02/01/2000 | US6020479 Amino acid transporters and uses |
| 02/01/2000 | US6020478 Human tumor-associated antigen |
| 02/01/2000 | US6020476 DAZ: a gene family associated with azoospermia |
| 02/01/2000 | US6020473 Nucleic acids encoding variants of vascular endothelial cell growth factor |
| 02/01/2000 | US6020469 Freeze drying (lyophilization) is considered useful and effective for preservation of many biologically active materials. |
| 02/01/2000 | US6020468 Antibodies directed against binding-associated epitopes |
| 02/01/2000 | US6020466 Myeloid cell leukemia associated gene mcl-1 |
| 02/01/2000 | US6020465 Recombinant avian type i interferon |
| 02/01/2000 | US6020464 Isolated Smad protein |
| 02/01/2000 | US6020463 Compositions and methods for the treatment and diagnosis of cardiovascular disease using rchd523 as a target |
| 02/01/2000 | US6020462 Nucleic acids encoding the hypoxia inducible factor-1 |
| 02/01/2000 | US6020460 Conformationally stabilized cell adhesion peptides |
| 02/01/2000 | US6020327 Control of hair growth |
| 02/01/2000 | US6020313 Method for inducing bone formation using an extract of human osteosarcoma cell line SAOS-2 |
| 02/01/2000 | US6020311 GRF analogs with increased biological potency |
| 02/01/2000 | US6020309 Pharmaceuticals based on papillomaviruses |
| 02/01/2000 | US6020307 Compositions and methods for isolating lung surfactant hydrophobic proteins SP-B and SP-C |
| 02/01/2000 | US6020306 Receptor-type tyrosine kinase and use thereof |
| 02/01/2000 | US6020212 Phycobiliprotein-linker peptide complex fluorescent tracer and methods of using the same |
| 02/01/2000 | US6020202 Composition and methods for transfecting eukaryotic cells |
| 02/01/2000 | US6020195 Antibodies against hepatitis G virus and their use for the diagnostic detection of HGV and as a therapeutic agent |
| 02/01/2000 | US6020193 Recombinant C-proteinase and processes, methods and uses thereof |
| 02/01/2000 | US6020192 Genes adapted for high level expression in mammalian cells, especially those of human origin. |
| 02/01/2000 | US6020191 Adenoviral vectors capable of facilitating increased persistence of transgene expression |
| 02/01/2000 | US6020190 Plant ubiquitin promoter system |
| 02/01/2000 | US6020189 Fibroblast growth factor homologous factors (FHFs) and methods of use |
| 02/01/2000 | US6020188 Polynucleotides encoding platelet endothelial cell adhesion molecule (PECAM-1) and fragments thereof |
| 02/01/2000 | US6020183 Analog of haemophilus Hin47 with reduced protease activity |
| 02/01/2000 | US6020182 Subunit respiratory syncytial virus vaccine preparation |
| 02/01/2000 | US6020177 Heptaprenyl diphosphate-synthetase |
| 02/01/2000 | US6020176 Converting copalyl pyrophosphate to ent-kaurene and are useful for the regulation of plant growth. |
| 02/01/2000 | US6020171 Method of preparing plasmid having both expressing ability of retroviral gene and processing ability after translation, and resultant plasmid and expression products thereof |
| 02/01/2000 | US6020169 Production of secreted foreign polypeptides in plant cell culture |
| 02/01/2000 | US6020168 Porcine CNP gene and precursor protein |
| 02/01/2000 | US6020167 Composition used as a therapeutic agent against chronic viral hepatic diseases |
| 02/01/2000 | US6020166 Nucleic acid encoding an altered telomere repeat binding factor 2 |
| 02/01/2000 | US6020165 Cytikine signal regulators |
| 02/01/2000 | US6020164 Human RNA binding proteins |
| 02/01/2000 | US6020163 Lipocalin homolog |
| 02/01/2000 | US6020162 Crystal of a protein-ligand complex containing an N-terminal truncated eIF4E, and methods of use thereof |
| 02/01/2000 | US6020161 PIGR-1, a member of immunoglobulin gene superfamily |
| 02/01/2000 | US6020160 For the treatment of infection, particularly bacterial infections. |
| 02/01/2000 | US6020159 3-dehydroquinate synthase |
| 02/01/2000 | US6020158 Intracellular g-protein complex which mediates further intracellular signaling activities generally the production of second messengers such as cyclic amp (camp), phospholipase c, inositol triphosphate or ion channel proteins. |
| 02/01/2000 | US6020157 Polynucleotides encoding HFGAN72X receptor |
| 02/01/2000 | US6020155 Nucleic acids encoding CR1 fusion protein, vector, transfected cell and expression |
| 02/01/2000 | US6020154 H. influenzae HxuB and HxuC genes, proteins and methods of use |
| 02/01/2000 | US6020152 Lymphocyte-associated cell surface protein |
| 02/01/2000 | US6020148 In vitro method for eye and skin irritation testing |
| 02/01/2000 | US6020145 Methods for determining the presence of carcinoma using the antigen binding region of monoclonal antibody BR96 |
| 02/01/2000 | US6020143 The invention is concerned with the identification, isolation and cloning of genes which are associated with alzheimer's disease. |
| 02/01/2000 | US6020142 Rath genes and polypeptides and methods for the treatment and diagnosis of immune disorders |
| 02/01/2000 | US6020140 Autoantibodies and their targets in the diagnosis of peripheral neuropathies |
| 02/01/2000 | US6020134 Method for diagnosing cancer via DNA hybridization |
| 02/01/2000 | US6020128 DNA polymerase from Treponema pallidum |
| 02/01/2000 | US6020127 Neuronal apoptosis inhibitor protein, gene sequence and mutations causative of spinal muscular atrophy |
| 02/01/2000 | US6020125 For use as antigens, immunogenic compositions, including vaccines, carriers for other antigens and immunogens and the generation of diagnostic reagents. |
| 02/01/2000 | US6020123 Oligonucleotide sequences for the amplification of the genome of the retroviruses of the HIV-2 and SIV type, and their uses for in vitro diagnosis of the infections due to these viruses |
| 02/01/2000 | US6020122 Hepatitis C virus second envelope (HCV-E2) glycoprotein expression system |
| 02/01/2000 | US6019987 Isolated, MAGE-3 derived peptides which complex with HLA-A2 molecules and uses thereof |
| 02/01/2000 | US6019984 Bacterial preparations, method for producing same, and their use as vaccines |
| 02/01/2000 | US6019983 Gnrh peptide conjugate to e. coli fimbrial-filaments and elicits an immune response against gnrh. |
| 02/01/2000 | US6019982 Mutant enterotoxin effective as a non-toxic oral adjuvant |
| 02/01/2000 | US6019980 Nucleic acid respiratory syncytial virus vaccines |
| 02/01/2000 | US6019978 Replication-defective adenovirus human type 5 recombinant as a vaccine carrier |
| 02/01/2000 | US6019974 SPE-4 peptides |
| 02/01/2000 | US6019973 Vaccine against enterotoxin-induced illness. |
| 02/01/2000 | US6019972 Peptides of human T cell reactive feline protein (TRFP) |
| 02/01/2000 | US6019969 Composition comprising antibody to macrophage-derived inflammatory mediator (MIP-α 1 and MIP-1β) |
| 02/01/2000 | US6019965 Alveolar proteinosis |
| 02/01/2000 | CA2171982C Drug binding protein |
| 02/01/2000 | CA2078097C Purple membrane preparations having increased holographic diffraction efficiency |
| 02/01/2000 | CA2069085C Activatable fibrinolytic and anti-thrombotic proteins |
| 02/01/2000 | CA2047681C Vaccines for nontypable haemophilus influenzae |
| 02/01/2000 | CA2035039C Recombinant poxvirus and streptococcal m protein vaccine |
| 02/01/2000 | CA2009198C Monoclonal antibody for differentiating hiv-2 from hiv-1 seropositive individuals |
| 02/01/2000 | CA1340888C Vaccines and diagnostic assays for haemophilus influenzae |
| 02/01/2000 | CA1340887C Sialic acid glycosides, antigens, immunoadsorbents, and methods for thier preparation |
| 01/27/2000 | WO2000004383A2 Hiv group o positive control |
| 01/27/2000 | WO2000004190A1 Evolution of whole cells and organisms by recursive sequence recombination |
| 01/27/2000 | WO2000004184A1 Bivalent binding molecules of 7 transmembrane g protein-coupled receptors |
| 01/27/2000 | WO2000004183A1 Bone morphogenic protein |
| 01/27/2000 | WO2000004177A1 Chromatin associated proteins |
| 01/27/2000 | WO2000004176A1 Process to collect metabolites from modified nectar by insects |
| 01/27/2000 | WO2000004174A1 Recombination repair gene, mim, from arabidopsis thaliana |
| 01/27/2000 | WO2000004172A1 Method of making proteins in transformed yeast cells |
| 01/27/2000 | WO2000004171A1 Treatment of diabetes with synthetic beta cells |
| 01/27/2000 | WO2000004170A1 Cleavage of caulobacter produced recombinant fusion proteins |
| 01/27/2000 | WO2000004167A2 Genes encoding sulfate assimilation proteins |